Home>CLSI NBS05 A Ed. 1 (2011)

CLSI NBS05 A Ed. 1 (2011)

CLSI NBS05 A Ed. 1 (2011) Newborn Screening For Cystic Fibrosis Specifies the use of newborn screening laboratory tests for detecting risk for cystic fibrosis from newborn dried blood spots (DBS) and addresses both the primary screening tests and the reflex tests

More details

Download

PDF AVAILABLE FORMATS IMMEDIATE DOWNLOAD
$85.80 tax incl.

$195.00 tax incl.

(price reduced by 56 %)

1000 items in stock

Table of Contents

Abstract
CommitteeMembership
Foreword
1Scope
2Introduction
3StandardPrecautions
4Terminology
5IntroductiontoNewbornScreeningforCystic
Fibrosis
6PathophysiologyofCysticFibrosisandImportance
ofEarlyDiagnosisthroughNewbornScreening
7ImmunoreactiveTrypsinogenasaPrimary
ScreeningTest
8CFTRMutations
9CurrentStrategiesandMethodsofCysticFibrosis
NewbornScreening
10LaboratoryMethodsforDNAAnalysisinCystic
FibrosisNewbornScreening
11GuidelinesforCFTRPanelsinImmunoreactive
Trypinogen/DNAScreening
12CysticFibrosisNewbornScreeningFollow-up
andVariations
13ProgramEvaluationandQualityAssurance
14CommunicatingResultsandFollow-upInformation
15ResearchOpportunities:Pancreatitis-Associated
ProteinDevelopment
References
Appendix-GeographicVariationsofCFTRAlleles
TheQualityManagementSystemApproach
RelatedCLSIReferenceMaterials

Abstract

Specifies the use of newborn screening laboratory tests for detecting risk for cystic fibrosis from newborn dried blood spots (DBS) and addresses both the primary screening tests and the reflex tests performed on DBS.

Contact us